Current Edition


As FDA scrutinizes immunotherapy approvals, Merck says Keytruda extends survival in liver cancer trial

The FDA has been under pressure to review the status of drugs granted accelerated approvals based on early data, as in some cases confirmatory trials …

Continue Reading →

Roche’s TECENTRIQ (Atezolizumab) Receives Priority Review

The new immunotherapy is being developed for the treatment of metastatic non-squamous non-small cell lung cancer. According to the International Agency for Research on Cancer, …

Continue Reading →